title: Induction of parturition with aglepristone in the Majorera goat.
abstract: This study assessed the efficacy of aglepristone at inducing parturition in pregnant goats. Six experimental groups were defined: group A-5 (n = 12), group A-3.3 (n = 12), group A-2.5 (n = 12) and group A-1.5 (n = 12) in which goats were injected SC once with 5.0, 3.3, 2.5 and 1.5 mg of aglepristone per kg body weight of goat, respectively, group L (n = 11), which was treated IM with 3.75 mg of luprostiol; and group Ct (n = 11), which was injected SC with 1 ml of saline solution. Different parameters associated with parturition were thereafter investigated. In addition, plasma progesterone concentrations were defined after treatments till parturition. Aglepristone effectively induced parturition in all of the goats. In the A-5, A-3.3 and A-2.5 groups, the time to parturition was around 30-34 h, and the majority of goats (97.2%, 35/36) started kidding between 25 and 40 h after the aglepristone injection. However, the goats in group A-1.5 showed a significantly (p < 0.01) higher time to parturition (mean: 46.8 h). Overall, the incidence of dystocia registered in aglepristone-induced goats (20.8%, 10/48) and luprostiol-induced goats was not different from that observed after a spontaneous parturition. The percentage of live kids was very similar between A-5, A-3.3, A.2.5 and L groups (95.7, 95.3, 95.0 and 96.3%, respectively) but was higher that observed in the control (83.4%) and A-1.5 (81.2%) groups. In addition, no maternal mortality was registered in any groups. No changes in plasma progesterone were observed during the first 24 h after treatment, and high plasma progesterone concentrations were present at kidding (6.7, 5.5, 4.5 and 3.6 ng/ml for groups A-5, A-3.3, A-2.5 and A-1.5, respectively), confirming that aglepristone does not induce parturition via luteolysis. This study demonstrates that aglepristone can be used to induce parturition in goats with satisfactory efficacy, inducing pregnancy termination without direct or immediate modifications of luteal function.
authors.affiliation: Obstetrics and Reproduction, Arucas, Spain Unit of Surgery, Faculty of Veterinary of Las Palmas, Arucas, Spain. mbatista@dpat.ulpgc.es
authors.forename: M
authors.initials: M
authors.lastname: Batista
authors.forename: R
authors.initials: R
authors.lastname: Reyes
authors.forename: M
authors.initials: M
authors.lastname: Santana
authors.forename: D
authors.initials: D
authors.lastname: Alamo
authors.forename: J
authors.initials: J
authors.lastname: Vilar
authors.forename: F
authors.initials: F
authors.lastname: González
authors.forename: F
authors.initials: F
authors.lastname: Cabrera
authors.forename: A
authors.initials: A
authors.lastname: Gracia
mesh_terms: D000818:Animals; D004963:Estrenes / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006041:Goats / Q000502:physiology*; D006727:Hormone Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D007751:Labor, Induced / Q000662:veterinary*; D007744:Obstetric Labor Complications / Q000662:veterinary; D036801:Parturition / Q000187:drug effects; D011247:Pregnancy
chemical_list: D004963:Estrenes; D006727:Hormone Antagonists; C419063:aglepristone